Premium
Pulmonary embolus in patients with COVID‐19: an Australian perspective
Author(s) -
Robinson Danielle H.,
Wimaleswaran Hari,
McDonald Christine F,
Howard Mark E.,
Willcox Abbey
Publication year - 2021
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.15405
Subject(s) - medicine , pulmonary embolus , covid-19 , complication , embolus , d dimer , pulmonary embolism , risk stratification , disease , coronavirus , respiratory disease , intensive care medicine , surgery , lung , infectious disease (medical specialty) , pathology , outbreak
Pulmonary embolus (PE) is a known complication of coronavirus disease 2019 (COVID‐19). The diagnosis of PE in our hospitalised patients with COVID‐19 correlated with more severe disease and occurred despite the use of routine thromboprophylaxis. Higher D‐dimers were seen on admission in patients who developed PE and rose at PE diagnosis, suggesting a role for D‐dimer in risk stratification.